| payload |
{"created_at":"2026-04-08T12:49:17.656 {"created_at":"2026-04-08T12:49:17.656805+00:00","signal_type":"discovery_new_listings_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/nurix-therapeutics-inc-nrix-reports-q1-loss-lags-revenue-estimates","value":{"fp":"03b9da51cf0840aa","kind":"new_listings","published_at":"2026-04-08T11:10:02+00:00","source":"Nasdaq Stocks","summary":"Nurix Therapeutics (NRIX) delivered earnings and revenue surprises of -4.22% and -57.21%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?","tickers":["NRIX"],"title":"Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates","url":"https://www.nasdaq.com/articles/nurix-therapeutics-inc-nrix-reports-q1-loss-lags-revenue-estimates"}}... |